| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;110:130-140
© 1995 Mosby, Inc.
GENERAL THORACIC SURGERY |
Durham, N.C.
Address for reprints: Walter G. Wolfe, MD, Duke University Medical Center, Box 3507, Durham, NC 27710.
Abstract
Positron emission tomography (PET), with the glucose analog F-18 fluorodeoxyglucose (FDG), takes advantage of the enhanced glucose uptake observed in neoplastic cells. We examined whether the detection of preferential FDG uptake with PET permits differentiation between benign and malignant focal pulmonary lesions in patients with suspected primary or recurrent lung cancer. Between November 1991 and September 1993, 100 patients with indeterminate focal pulmonary abnormalities including 16 patients who had previous lung resections for cancer were prospectively studied. Tissue diagnosis was obtained by transbronchial or percutaneous biopsy (n = 49) and open biopsy or resection (n = 35). Three patients underwent extended observation (>2 years) alone. Excluded were 13 patients lacking firm pathologic diagnoses and less than 2-year follow-up. FDG activity in the lesion was expressed as a calculated standardized uptake ratio. Mean standardized uptake ratio (±standard deviation) was 6.6 (±3.1) in 59 patients with cancer versus 2.0 (±1.6) in 28 with benign disease (p = 0.0001; unpaired t test, two-sided). With a standardized uptake ratio 2.5 used for detecting malignancy, sensitivity, specificity, and accuracy were 97% (57/59), 82% (23/28), and 92% (80/87), respectively. Notably, in patients evaluated for pulmonary abnormalities after lung resection for cancer, all chest recurrences were correctly identified. The exceptional sensitivity of FDG PET demonstrates that malignant pulmonary lesions preferentially accumulate FDG, which results in a standardized uptake ratio 2.5. PET may be useful for distinguishing recurrent tumor from postoperative, or postradiation, changes. If performed in all patients before open biopsy, PET increases the diagnostic yield by reducing the number of patients who have benign lesions at operation. Moreover, by lowering expenditures for hospitalization and other diagnostic procedures, FDG PET may significantly reduce health care costs. (J THORAC CARDIOVASC SURG1995;110:130-40)
This article has been cited by other articles:
|
|
 |
|
  C.-J. Chen, B.-F. Lee, W.-J. Yao, L. Cheng, P.-S. Wu, C. L. Chu, and N.-T. Chiu Dual-Phase 18F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5 Am. J. Roentgenol., August 1, 2008; 191(2): 475 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Hoang, L. F. Hoagland, R. E. Coleman, A. D. Coan, J. E. Herndon II, and E. F. Patz Jr Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non-Small-Cell Lung Carcinoma J. Clin. Oncol., March 20, 2008; 26(9): 1459 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cronin, B. A. Dwamena, A. M. Kelly, and R. C. Carlos Solitary Pulmonary Nodules: Meta-analytic Comparison of Cross-sectional Imaging Modalities for Diagnosis of Malignancy Radiology, March 1, 2008; 246(3): 772 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hellwig, T. P. Graeter, D. Ukena, A. Groeschel, G. W. Sybrecht, H.-J. Schaefers, and C.-M. Kirsch 18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense? J. Nucl. Med., November 1, 2007; 48(11): 1761 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Wahidi, J. A. Govert, R. K. Goudar, M. K. Gould, and D. C. McCrory Evidence for the Treatment of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 94S - 107S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Gould, J. Fletcher, M. D. Iannettoni, W. R. Lynch, D. E. Midthun, D. P. Naidich, and D. E. Ost Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 108S - 130S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bunyaviroch and R. E. Coleman PET Evaluation of Lung Cancer J. Nucl. Med., March 1, 2006; 47(3): 451 - 469. [Full Text] [PDF]
|
|
|
|
|
|
L. K. Shankar and D. C. Sullivan Functional Imaging in Lung Cancer J. Clin. Oncol., May 10, 2005; 23(14): 3203 - 3211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Downey, T. Akhurst, M. Gonen, A. Vincent, M. S. Bains, S. Larson, and V. Rusch Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer Resection J. Clin. Oncol., August 15, 2004; 22(16): 3255 - 3260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Rohren, T. G. Turkington, and R. E. Coleman Clinical Applications of PET in Oncology Radiology, May 1, 2004; 231(2): 305 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. V. Gonzalez-Stawinski, A. Lemaire, F. Merchant, E. O'Halloran, R. E. Coleman, D. H. Harpole, and T. A. D'Amico A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1900 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Gould, G. D. Sanders, P. G. Barnett, C. E. Rydzak, C. C. Maclean, M. B. McClellan, and D. K. Owens Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules Ann Intern Med, May 6, 2003; 138(9): 724 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Graeter, D. Hellwig, K. Hoffmann, D. Ukena, C.-M. Kirsch, and H.-J. Schafers Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy Ann. Thorac. Surg., January 1, 2003; 75(1): 231 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D R Baldwin, T Eaton, J Kolbe, T Christmas, D Milne, J Mercer, E Steele, J Garrett, M L Wilsher, and A U Wells Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions? Thorax, September 1, 2002; 57(9): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Wax, L. L. Myers, E. C. Gabalski, S. Husain, J. M. Gona, and H. Nabi Positron Emission Tomography in the Evaluation of Synchronous Lung Lesions in Patients With Untreated Head and Neck Cancer Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 703 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Marom, S. Sarvis, J. E. Herndon, and E. F. Patz Jr T1 Lung Cancers: Sensitivity of Diagnosis with Fluorodeoxyglucose PET Radiology, May 1, 2002; 223(2): 453 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.F. Vansteenkiste Imaging in lung cancer: positron emission tomography scan Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis JAMA, February 21, 2001; 285(7): 914 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-U. Hung, Y.-C. Shiau, S.-C. Tsai, Y.-J. Ho, C.-H. Kao, and R.-F. Yen Differentiation of Radiographically Indeterminate Solitary Pulmonary Nodules with [18F]Fluoro-2-deoxyglucose Positron Emission Tomography Jpn. J. Clin. Oncol., February 1, 2001; 31(2): 51 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. McCain, D. P. Dunagan, R. Chin Jr., T. Oaks, B. A. Harkness, and E. F. Haponik The Usefulness of Positron Emission Tomography in Evaluating Patients for Pulmonary Malignancies Chest, December 1, 2000; 118(6): 1610 - 1615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Goo, J.-G. Im, K.-H. Do, J. S. Yeo, J. B. Seo, H. Y. Kim, and J.-K. Chung Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 Cases Radiology, July 1, 2000; 216(1): 117 - 121. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kosuda, K. Ichihara, M. Watanabe, H. Kobayashi, and S. Kusano Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan Chest, February 1, 2000; 117(2): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Graeber, N. C. Gupta, and G. F. Murray POSITRON EMISSION TOMOGRAPHIC IMAGING WITH FLUORODEOXYGLUCOSE IS EFFICACIOUS IN EVALUATING MALIGNANT PULMONARY DISEASE J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 719 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text]
|
|
|
|
|
|
V. J. Lowe and K. S. Naunheim Positron Emission Tomography in Lung Cancer Ann. Thorac. Surg., June 1, 1998; 65(6): 1821 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Virgo, K. S. Naunheim, L. W. McKirgan, M. E. Kissling, J. C. Lin, and F. E. Johnson COST OF PATIENT FOLLOW-UP AFTER POTENTIALLY CURATIVE LUNG CANCER TREATMENT J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 356 - 363. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
